Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials.
about
The influence of antiphospholipid antibodies on the pregnancy outcome of patients with recurrent spontaneous abortionWhy did your mother reject you? Immunogenetic determinants of the response to environmental selective pressure expressed at the uterine level.Secondary recurrent miscarriage and H-Y immunity.H-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients and associated with low male : female ratio in subsequent live births.Pregnancy loss and thrombophilia: the elusive link.Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF).Is there any evidence for immunologically mediated or immunologically modifiable early pregnancy failure?Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?Evaluation of CD56(dim) and CD56(bright) natural killer cells in peripheral blood of women with IVF failures.Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF).Progesterone, selected heavy metals and micronutrients in pregnant Nigerian women with a history of recurrent spontaneous abortion.Association of progesterone receptor polymorphisms with recurrent implantation failure after in vitro fertilization and embryo transfer.Immunological factors in pregnancy wastage: fact or fiction.Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science.Does immunotherapy for treatment of reproductive failure enhance live births?Mouse is the new woman? Translational research in reproductive immunology.The globular heads of the C1q receptor regulate apoptosis in human extravillous cytotrophoblast-derived transformed cells via a mitochondria-dependent pathway.Psycho-neuro-cytokine/endocrine pathways in immunoregulation during pregnancy.The emerging role of immunoregulation of fibrinogen-related procoagulant Fgl2 in the success or spontaneous abortion of early pregnancy in mice and humans.Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin.Shall we properly re-examine the status of allogeneic lymphocyte therapy for recurrent early pregnancy failure?The effect of maternal age on chromosomal anomaly rate and spectrum in recurrent miscarriage.
P2860
Q28191405-980850EF-5545-463A-9FFE-E31795721C66Q33546312-4F301503-02FB-4BDB-885A-41B7B2B97B80Q34177424-700284B9-E4CC-42D1-B38C-B7FA031BAB0EQ34202524-2ED631EB-66EB-4A9C-9AB1-8F0503D54553Q34263740-25D06012-32B0-42D8-9885-0FD5D6628D99Q34424885-12F05543-A6DA-4461-9CE0-9B973F771E05Q35104552-38854C02-C6EE-4AB5-A707-364BAD1D72C8Q35915182-07B62776-DB2F-412D-A720-89736C6E7A4CQ36260025-7696DC3F-7ABA-4AA4-BAC2-866DF0B79AE2Q36270374-16A184C3-37DB-41CA-B79A-E59ED194048DQ36292413-9F840170-6172-4294-B89F-7CE69379AF4EQ36970122-902390A6-08AD-4EA2-988B-397D3E6536E5Q37108648-1E60608D-C7B0-4D96-9BAC-9527C700D5D5Q37773248-175AF08E-8990-44FC-8454-AC3037CF7AE4Q37984847-66858F9E-460C-4C5D-930B-175516D2CD47Q38701730-BECF4C05-0605-4DA4-B767-2FF79DA0141CQ39096825-9F93F283-CA95-45B5-8E58-49FBC92EFD1DQ41062878-2DD92F65-AD98-4B38-A915-5D68AE99447EQ42475625-F67F140A-F1E9-47D6-8F79-780AFFB2FBF8Q46620083-51B4D421-6E27-493A-B085-9339551D06A5Q47263740-64455DCD-9BA7-40EA-B539-0C0C6F780CBEQ49101368-D74C3256-8287-465A-BF80-8324F76239AA
P2860
Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials.
@en
type
label
Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials.
@en
prefLabel
Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials.
@en
P2093
P2860
P1476
Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials.
@en
P2093
P2860
P304
P356
10.1111/J.1600-0897.1996.TB00493.X
P577
1996-04-01T00:00:00Z